ZEB1 and non-small cell lung carcinoma: ZEB1 is involved in EMT‐mediated acquired resistance to gefitinib in EGFR‐mutant NSCLC cells,22 although the biological significance of ZEB1 in the lung CSCs contributing to acquired resistance to gefitinib has not been fully elucidated.